MeSH tree: D27.505.696.422.750
A new study led by UCLA Health found that a large percentage of disadvantaged patients are not taking their diabetes medications consistently. The analysis of national health records for 587,000 Medicare Advantage patients ...
Sep 24, 2026
0
4
Type 2 diabetes increases the risk of chronic kidney disease, making prevention of kidney failure a key part of treatment. Newer diabetes medications, including GLP-1s and SGLT2 inhibitors, can reduce the risk of kidney disease, ...
Sep 16, 2026
0
12
A study of adults with type 2 diabetes recovering from dialysis-requiring acute kidney injury found that patients who began an SGLT-2 inhibitor within 30 days of hospital discharge had fewer serious kidney events than those ...
Sep 10, 2026
0
6
Patients receiving cancer treatment often face the added complication of side effects affecting the heart, which can lead to the need to discontinue anticancer therapy, reducing its effectiveness. Researchers from the Erasmus ...
Jun 19, 2026
0
4
Once-weekly cagrilintide, an amylin receptor agonist, plus semaglutide is efficacious for adults with type 2 diabetes inadequately controlled with diet and exercise, receiving metformin with or without a sodium glucose cotransporter ...
Jun 12, 2026
0
9
For adults with type 2 diabetes (T2D) not on insulin therapy (NIT), continuous glucose monitoring (CGM) is associated with a substantial reduction in glycated hemoglobin (HbA1c), according to a study presented at the annual ...
Jun 11, 2026
0
9
New research presented at the 63rd ERA Congress suggests that a widely used class of blood pressure medications may be associated with poorer kidney outcomes in people with type 2 diabetes (T2D), even among patients already ...
Jun 4, 2026
0
12
A clinical decision support system (CDSS) for chronic kidney disease (CKD) does not improve physician behavior or patient outcomes over a control intervention, according to a study published online May 8 in JAMA Network Open.
May 14, 2026
0
6
Older adults with type 2 diabetes face a difficult trade-off: they are among the most vulnerable to medication-related harms yet are often underrepresented in the clinical trials that guide treatment decisions. A new study ...
Apr 29, 2026
0
12
People who live with obesity are "tagging" a memory of being overweight on a key part of the immune system—leaving people with ongoing risk of obesity-related conditions years after losing weight, according to a 10-year-long ...
Apr 27, 2026
0
19
